The amygdala is a key limbic structure involved in emotion processing, fear conditioning, and reward learning. In Parkinson's disease (PD), the amygdala is affected by alpha-synuclein pathology and shows functional alterations that contribute to non-motor symptoms including anxiety, depression, and情绪障碍.
The amygdala contains diverse neuronal populations:
- Pyramidal neurons: The principal cell type in basolateral and central nuclei
- GABAergic interneurons: Parvalbumin, somatostatin, and cholecystokinin subtypes
- Intercalated cells: Small GABAergic neurons that modulate amygdala output
- Projection neurons: Major output cells of the basolateral complex
- High density of dendritic spines
- Extensive local connections
- Diverse afferent and efferent projections
¶ Markers and Neurochemistry
Key markers for amygdala neurons:
- Calbindin: Expressed in specific subpopulations
- Neuropeptide Y: In somatostatin-positive interneurons
- Dopamine receptors: D1, D2 expressed in various nuclei
- Serotonin receptors: 5-HT2A, 5-HT2C prevalent
- CRH: Corticotropin-releasing hormone in stress circuits
The amygdala accumulates Lewy bodies:
- Early alpha-synuclein deposition
- Affects both principal neurons and interneurons
- Correlates with emotional symptoms
¶ Anxiety and Depression
Amygdala dysfunction contributes to:
- Heightened anxiety responses
- Depressive symptom severity
- Emotional processing biases
- Reduced reward sensitivity
Altered fear circuitry:
- Exaggerated fear responses
- Impaired fear extinction
- Reduced safety signal learning
Central amygdala affects:
- Cardiovascular responses
- Stress hormone release
- Autonomic dysregulation in PD
Amygdala shows:
- Lewy body accumulation
- Neuronal loss in central nucleus
- Functional connectivity changes
- Correlation with neuropsychiatric symptoms
More severe amygdala involvement:
- Greater alpha-synuclein burden
- More pronounced emotional symptoms
- Earlier onset of neuropsychiatric features
Amygdala contributes to:
- Visual hallucination generation
- Misperception formation
- Reduced reality monitoring
¶ SSRIs and SNRIs
First-line for amygdala-related symptoms:
- Reduce amygdala hyperreactivity
- Improve emotional processing
- May slow progression of emotional symptoms
May help:
- Reduce amygdala overactivity
- Improve emotional recognition
- Address neuropsychiatric components
STN DBS may affect:
- Modulate limbic circuits
- Reduce anxiety
- Improve emotional processing
- Locus Coeruleus Noradrenergic Neurons
- Raphe Nucleus Serotonergic Neurons in Parkinson's Disease
- Substantia Nigra Dopamine Neurons in Parkinson's Disease
- Amygdala - Wikipedia